Abstract In animal models of spinal cord injury (SCI), inducible NO (nitric oxide) synthase is expressed in the spinal cord immediately after sustaining SCI. Excessive NO production has cytotoxic effects and induces neuronal apoptosis, causing neural degeneration and neurodysfunction in the spinal cord. Little is known, however, about the relationship between NO x (NO metabolites: nitrite and nitrate) levels in the cerebrospinal fluid (CSF) and neurologic severity or recovery in clinical cases. The objective of the present study was to examine the correlation between CSF NO x levels and neurologic severity or recovery in SCI. Twenty-five patients with incomplete cervical cord injury (CCI) were examined. Eight cases were treated conservatively (non-operated group). Seventeen cases underwent surgical intervention (operated group). NO x levels in the CSF were measured using the Griess method. The severity of the neurologic impairment was assessed using Frankel's classification and the American Spinal Injury Association motor score (ASIA MS). The degree of neurologic recovery was assessed using Frankel's classification and the ASIA motor recovery percentage (MRP). There was no significant difference in the NO x levels between the CCI group (NO x levels: 5.9 ± 0.7 lM) and the 36 control subjects (1 volunteer and 35 patients without neurologic disorders, NO x levels: 4.9 ± 0.3 lM). There was no significant difference in NO x levels and MRP between the non-operated group and the operated group. The NO x levels in total SCI group were significantly correlated with the ASIA MS and MRP. There was a significant correlation between CSF NO x levels and neurologic severity or recovery in incomplete CCI.
Introduction
Patients with spinal cord injury (SCI), often suffer permanent paresis, resulting in severe physical, emotional, and economic loss for them and their family. Therefore, immediate treatment and prognostic prediction at the acute stage are required to efficiently rehabilitate the patient to obtain the maximum achievable quality of life.
The prognosis of SCI is usually predicted using the Frankel classification [11, 24] or the findings of magnetic resonance images, such as intramedullary signal changes, the longitudinal length of the haematoma, or edema in the spinal cord at the acute stage [30] . It is not easy to clinically predict the prognosis at the acute stage, however, because the paresis due to spinal cord shock is variable [11] . Currently, there are no quantitative predictors for neurologic improvement at the acute stage.
In SCI, initial mechanical injuries occur, followed by secondary injuries, such as ischemia, edema, and leukocyte infiltration into the spinal cord parenchyma [31] . The secondary injuries lead to neuronal apoptosis and spinal cord degeneration [4] . Nitric oxide (NO), a gaseous messenger that induces vasodilatation [26] and macrophage cytotoxicity [14] , and is involved in neural signaling [17, 18] is a physiologic biofactor involved in secondary injury in SCI.
We previously reported that preoperative concentrations of NO metabolites (NO x levels) in the cerebrospinal fluid (CSF) are higher in patients with lumbar degenerative diseases than in pain-free controls [19] and are significantly correlated with the degree of pain relief following surgery. Therefore, NO x levels are possible quantitative predictors of pain relief in lumbar degenerative diseases [20, 21] .
In animal experiments of SCI, inducible NO synthase (iNOS) is expressed in the spinal cord immediately after SCI, reaches a maximal value at 12 h, and is maintained at this level of expression for 1 week [13, 28, 33] . Excessive NO production derived from iNOS has cytotoxic effects [5] and induces neuronal apoptosis, causing neural degeneration and neurodysfunction [1, 9] . Compared to wild-type mice, iNOS-gene deficient mice have a significantly better functional outcome after SCI [15] . Administration of a NOS blocker reduces neurologic deterioration [3] . Little is known, however, about the relationship between NO x levels and neurologic severity or recovery in clinical SCI cases. Therefore, in the present study, we examined whether CSF NO x levels correlate with the severity and prognosis of neurologic recovery from SCI.
Materials and methods

Subjects
Informed consent was obtained from all participating subjects. Twenty-five patients with incomplete cervical cord injury (CCI group), who were admitted to the hospital between January 1998 and December 2004, were examined. The CCI group consisted of 18 males and 7 females (age range 30-85 years; mean 61 years). The follow-up period ranged from 9 to 45 months (mean 17 months). The CCI group all had initial symptoms such as numbness or paresis immediately after evident trauma (fall 17 cases, traffic accident 6, cervical sprain 1, compression by machine 1). The CCI group was composed of 16 cases with radiologic spondylosis, 2 cases without spondylotic changes, 4 cases with ossification of the posterior longitudinal ligament (OPLL), 1 case with developmental canal stenosis, and 2 cases with cervical fracture and dislocation. The injured levels in the spine were as follows: C1/2 (n = 1), C3/4 (n = 9), C4/5 (n = 12), C5/6 (n = 2), C6/7 (n = 1).
Eight cases were treated conservatively (non-operated group). Seventeen cases underwent surgical intervention [operated group; anterior spinal fusion (n = 7), cervical laminoplasty (n = 10)]. Surgical intervention was indicated in cases of spinal cord compression with OPLL, developmental canal stenosis, or bulging discs; or abnormal spinal instability due to disc injury and/or ligamentous injury of the anterior longitudinal ligament or inter-or supraspinous ligaments. Intravenous methylprednisolone was administered in 21 cases (7 cases in the non-operated group; 14 cases in the operated group) according to the protocol based on the second National Acute Spinal Cord Injury Study (NASCIS II) [3] . Methylprednisolone has an antiinflammatory effect, and might decrease CSF NO x levels.
The control group consisted of 36 cases (CON group) with 1 healthy volunteer that had neither pain nor neurologic disorders, and 35 patients with inguinal herniation (n = 11), or who were undergoing removal of metal instrumentation following a fracture in the lower extremity (n = 24). The CSF in the CON group was obtained just before lumbar anesthesia. The CON group ranged in age from 34 to 76 years (mean 55 years). The CCI and CON groups were matched for age.
Measurement of NO metabolites
In the CON group, CSF (1-2 cc) was collected using a spinal needle (23-25 gauge) at L2/3 or L3/4 under lumbar anesthesia. In a healthy volunteer, CSF was obtained using a spinal needle (25 gauge) at L3/4. In the CCI group, CSF was obtained during conservative treatment or preoperatively. The timing of CSF collection ranged from between 0 and 30 days (mean 5 days; 0-5 days, 18 cases; 6-13 days, 6 cases; 14-30 days, 1 case), usually within 14 days after SCI, although high NO x levels persist for up to 2 weeks in animal studies. Also, in 7 cases CSF was obtained twice, at the acute phase within 1 day (mean 0.9 days) and at the subacute phase between 5 and 21 days (mean 9.6 days) after the trauma. To elucidate the relationship between changes in NO x levels and recovery rate, the change in NO x was calculated using the following equation [20] : changes in NO x levels = (2nd NO x levels À 1st NO x levels)/1st NO x levels · 100 (%). The specimens were stored at À20°C for later measurement of NO metabolites, NO 2 À plus NO 3 À (NO x levels). The measurement was performed within 6 months after CSF collection. NO x in frozen human plasma is stable for at least 1 year [27] . CSF NO x levels were measured based on the Griess method [12] , as reported previously [19] . Methanol (200 ll) was added to deproteinize the CSF (1:1) followed by centrifugation (5,000g, 10 min) to avoid occlusion of the polystyrene polymer column in this system by protein or macromolecules. The assay was performed with an NO analyzer (ENO-20, Eicom Corp, Kyoto, Japan). In brief, the NO analyzer was first calibrated using a standard solution (100 pM NO 2 À and 100 pM NO 3 À ). NO 2 À and NO 3 À were separated on the polystyrene polymer column. NO 3 À was reduced by a cadmium column to form NO 2 À . NO 2 À was mixed with Griess reagent to form a purple azo dye. The absorption at 540 nm was measured by a flow-through spectrophotometer. The concentration of NO x was measured by assessing the peak area of the absorption using a computer (PowerChrom, Eicom). The minimal detectable level of NO 2 À or NO 3 À was 0.01 lM. The reproducibility and accuracy of this system was previously confirmed [19] .
Comparison of NO x levels between CON and CCI groups CSF NO x levels were compared between CON and CCI groups.
Evaluation of neurologic severity and recovery in CCI
The severity of neurologic impairment was assessed using Frankel's classification [11] as well as the American spinal injury association motor score (ASIA MS) [25] at initial admission and the final follow-up. Frankel's classification was categorized as A (complete motor and sensory loss), B (preserved sensory only), C (preserved useless motor activity), D (preserved useful motor activity), and E (complete neurologic recovery). In the present study, Frankel A, B, and C classifications were defined as the Useless group. Frankel D was defined as the Useful group. ASIA MS was based on 10 key muscles associated with the critical neurologic levels of the spinal cord. To investigate the relationship between the NO x levels and neurologic severity, NO x levels were compared with ASIA MS. The degree of neurologic recovery was assessed by Frankel's classification and ASIA motor recovery percentage (MRP) at the final follow-up. The MRP was calculated using the following equation: MRP (%) = {(motor score at follow-up À initial motor score)/(full score À initial motor score)} · 100 [6, 7, 16] . The MRP was calculated for all 25 cases. The NO x levels and MRP were compared between non-operated and operated groups.
Data analysis
Data are expressed as the mean ± SE. The difference in means between two groups was tested using the MannWhitney U test. Correlations were performed by Spearman's ranked correlation coefficient. A P value of less than 0.05 was considered statistically significant. No statistical significance is presented as n.s. in the figures.
Results
CSF NO x levels in CON and CCI groups
There was no significant difference in the NO x levels between the CON (4.9 ± 0.3 lM) and CCI (5.9 ± 0.7 lM) groups (Fig. 1) although those in the CCI group tended to be higher than those in the CON group and have considerable variability.
Correlation between the NO x levels and severity of neurologic impairment
The NO x levels at the initial evaluation in the Useless group (n = 10, 7.3 ± 0.8 lM) were significantly higher (P < 0.05, Fig. 2a ) than those in the Useful group (n = 15, 5.0 ± 1.1 lM). There was a significant correlation between the NO x levels and ASIA MS (P < 0.05, r = À0.45, Fig. 2b ). These data indicate that NO x levels in CCI group correlate with the severity of neurologic impairment.
Correlation between the NO x levels and neurologic recovery There were no cases classified as Frankel A; 1 Frankel B; 9 Frankel C; 15 Frankel D at the initial evaluation. At the final follow-up, one case classified as Frankel B improved (Fig. 3a) . There was no significant difference in NO x levels and MRP between the non-operated group (n = 8, NO x levels 7.0 ± 1.4 lM, MRP 62 ± 15%) and the operated group (n = 17, 5.4 ± 0.9 lM, 83 ± 5%). There was no significant correlation between a change in NO x levels and MRP. There was a significant negative correlation between the NO x levels and MRP at follow-up in the 25 cases (P < 0.01, r = À0.67, Fig. 3b) , as well as, in the 21 cases (P < 0.01, r = À0.64) administered methylprednisolone based on the NASCIS II [3] , although the two groups with (n = 21, MRP 77 ± 6%) and without methylprednisolone (n = 4, MRP 75 ± 25%) were not statistically comparable due to the small number patients without methylprednisolone. These data indicate that NO x levels in CCI correlate with neurologic recovery.
Discussion
Increase in NO x levels in SCI
In animal experiments of SCI, there are several reports indicating a significant increase in iNOS expression or NO around the injured spinal cord. Hamada and colleagues demonstrated that iNOS mRNA at the SCI lesion reaches a maximum 24 h after SCI [13] . Xu and co-workers reported a progressive increase in iNOS expression in the injured spinal cord with maximal expression on day 7, and that the high levels of iNOS expression persist for 2 weeks after SCI [33] . Nakahara reported that NO increases with biphasic changes, such as 1-12 and 24 h to 3 days after injury [28] . These animal studies support the finding that NO metabolites in the CSF increase from 1 day to 2 weeks after SCI, even in human. In the CCI group, however, NO x levels did not increase significantly in the present study. This might be due to the fact that the CCI group included mostly cases with only mild neurologic deficits (Frankel B, 1; C, 9; D, 15 cases). The NO x levels were significantly higher in Frankel B, and C groups (Useless group) than in the Frankel D group (Useful) (Fig. 2a) . There was a significant correlation between the NO x levels and ASIA MS (Fig. 2b) . Collectively, NO x levels are indicators of the severity of neurologic impairment.
High NO concentrations induce neural dysfunction NO, in general, has both cytoprotective and cytotoxic effects, although these effects have not been precisely determined. Physiologic NO levels are not highly toxic. NO reacts with O 2 À to form the powerful oxidant, peroxynitrite (ONOO À ), however, which directly oxidizes lipids, DNA, and proteins [23] . Excessive NO production derived from iNOS has cytotoxic effects [1, 5, 13] and induces neuronal apoptosis [9] , causing degeneration and neurodysfunction in the spinal cord. Emery and co-workers [8] confirmed the presence of apoptotic cells in the white matter around the SCI site in clinical cases. These data suggest that high concentrations in NO induce a high rate of neuronal apoptosis and neural degeneration in SCI.
Significant correlation between NO metabolites in CSF and neurologic recovery in CCI Based on the analysis of 1,461 SCI cases, the Frankel classification at the acute phase is predictive of neurologic Fig. 2 Correlation between the NO x levels and severity of neurologic impairment. The NO x levels in the Useless group (Frankel A, B, and C) were significantly higher than those in the Useful group (Frankel D) (a). There is a significant negative correlation between the NO x levels and the ASIA (American spinal injury association) motor score (b) Fig. 3 An alteration in Frankel's classification and correlation between the NO x levels and neurologic recovery. Initial and Follow-up represent Frankel classification at initial evaluation and at the final follow-up, respectively (a). There is a significant negative correlation between the NO x levels and MRP (motor recovery percentage) (b) prognosis because 3.0% of cases with Frankel A, 31.3% of cases with Frankel B, and 70.7% of cases with Frankel C recovered to at least a Frankel D at 1-year follow-up [24] . Seldon and co-workers [30] demonstrated that the spreading and lengthening of intramedullary T2 signal intensity in the spinal cord on magnetic resonance images are predictors of neurologic prognosis. In a previous clinical study of SCI, leukotriene C 4 levels, which are a metabolite of arachidonic acid (eicosanoids), in CSF increase at the acute stage of injury and correlate with severity of neurologic impairment [29] . To our knowledge, however, there are no quantitative predictors for neurologic recovery in SCI at the acute stage. The present study indicates that the NO x levels are significantly correlated with neurologic recovery in SCI based on MRP, although there is a great deal of overlap between the groups; for instance, there were patients with 0% MRP who had the same NO level as patients with 100% recovery (Fig. 3b) . Therefore, the NO x levels are possible quantitative predictors for neurologic recovery in incomplete CCI.
Limitations and problems in the present study
There are several problems regarding the measurement of NO x levels in CSF. First, subarachnoid hemorrhage might contaminate CSF NO x levels after SCI because in bovine the NO x levels in plasma are eight times higher than those in the CSF [2] . In our previous study, however, CSF NO x levels were not affected by blood contamination [32] . The second is an imbalance in the severity of neurologic impairment in the patient series. The majority of the patients were classified as Frankel C (n = 9) and Frankel D (n = 15), while the number of severe cases was quite small. This imbalance means that our results might not pertain to severe cases. Therefore, the recovery rate in severe cases should be analyzed further to confirm the relationship between NO x levels and the neurologic recovery rate. The third is concurrent analysis of the non-operated and operated cases. These two groups might have different outcomes. There are no randomized control studies, however, showing that surgical intervention is superior to conservative treatment [10] .
Clinical application for an NOS blocker and related drugs for SCI Pharmacologic studies indicate that motor function is improved by preventing NO production after SCI in animal experiments. Hamada et al. [13] reported that intravenous injection of an iNOS inhibitor, N G -nitro-L-arginine methyl ester, reduces motor dysfunction in SCI models. La Rosa and colleagues [22] also reported that administration of pyrolidine dithiocarbamate (PDTC), which inhibits the activation of NF-jB and thus reduces iNOS expression, significantly improves motor function. These experimental results suggest that a NOS blocker and PDTC are candidate future pharmacologic treatments for SCI in humans. To improve the neurologic prognosis in human SCI, the side effects as well as the clinical effectiveness of these drugs remain to be clarified.
